Key result
Adding radiomics to clinical-CTA models fails to significantly improve identification of symptomatic sIVBD.
Why the study?
Spontaneous intracranial vertebrobasilar artery dissection has heterogeneous clinical presentations, and conventional clinical and morphologic assessments may not fully characterize lesion heterogeneity to differentiate symptomatic from asymptomatic unruptured cases.
Does a combined model integrating clinical variables, conventional CTA features, and subtraction CTA-based radiomics improve the differentiation of symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection compared to conventional clinical and CTA assessment alone?
Cross-Sectional (n=173)
No
Does a combined model integrating clinical variables, conventional CTA features, and subtraction CTA-based radiomics improve the differentiation of symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection compared to conventional clinical and CTA assessment alone?
Integrating subtraction CTA-based radiomics with clinical and conventional CTA morphological features improves the differentiation of symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection.
Answers are grounded in this paper and cite their sources.
Radiomics addition yielded nonsignificant AUC gain (p=0.136); hypothesis-generating for sIVBD stratification and requires prospective validation.
Background Spontaneous intracranial vertebrobasilar artery dissection (sIVBD) has heterogeneous clinical presentations, and conventional clinical and morphologic assessment may not fully characterize lesion heterogeneity. We aimed to develop and internally validate CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured sIVBD and to evaluate the incremental contribution of radiomics beyond conventional clinical and CTA features. Methods This retrospective single-center study included 173 patients with unruptured sIVBD, comprising 56 symptomatic and 117 asymptomatic patients. Patients were stratified into a development cohort ( n = 138) and an independent internal validation cohort ( n = 35). Radiomic features were extracted from subtraction CTA images after three-dimensional lesion segmentation. Feature reproducibility was assessed using inter-reader intraclass correlation coefficients. Four models were developed: a conventional CTA model (M1), a clinical plus conventional CTA model (M2), a radiomics XGBoost model (M3), and a combined model integrating M2 predictors with a cross-fitted radiomics probability (M4). Primary development-cohort evaluation used five-times-repeated five-fold stratified nested cross-validation. Discrimination, calibration, Brier score, and decision-curve analysis were assessed. Results Of 851 radiomic features, 722 (84.8%) met the prespecified reproducibility criterion. In patient-averaged out-of-fold evaluation, AUCs were 0.630 for M1, 0.681 for M2, 0.676 for M3, and 0.723 for M4. Compared with M2, M4 increased AUC by 0.0416 (95% CI, −0.0130 to 0.0962; p = 0.136) and reduced the Brier score by 0.0101 (95% bootstrap CI, −0.0208 to 0.0006). Across 25 outer folds, M4 had the highest mean AUC (0.715) and the lowest between-fold variability. In the independent internal validation cohort, AUCs were 0.814, 0.807, 0.803, and 0.966 for M1 through M4, respectively. Conclusion A combined model integrating clinical variables, conventional CTA features, and cross-fitted radiomics information showed the best overall performance for differentiating symptomatic from asymptomatic unruptured sIVBD. Radiomics may provide complementary quantitative information beyond conventional assessment.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) conducted a cross-sectional in Unruptured spontaneous intracranial vertebrobasilar artery dissection (sIVBD) (n=173). Combined model integrating clinical variables, conventional CTA features, and cross-fitted radiomics probability (M4) vs. Clinical plus conventional CTA model (M2) was evaluated on Differentiation of symptomatic from asymptomatic status at clinical evaluation (patient-averaged out-of-fold ROC-AUC in the development cohort) (ΔAUC 0.0416, 95% CI -0.0130 to 0.0962, p=0.1357). A combined clinical, conventional CTA, and radiomics model (M4) achieved an out-of-fold AUC of the clinical-CTA model for classifying symptomatic sIVBD.
Synapse has enriched 10 related papers. Consider them for comparative context: